• Angus, J.A., Chesher, G.B., Cobbin, L.B., Einstein, R., Goodman, A.H., Jackson, D.M. & Starmer, G.A. (1971). Some cardiovascular effects of Δ9-tetrahydrocannabinol in the conscious dog. Proc. Aust. Soc. Clin. Exper. Pharmacol., 5, 46.
  • BOŚE, B.C., Saifi, A.Q. & Bhagat, A.W. (1963). Effect of cannabis indica on hexobarbital sleeping time and tissue respiration of rat brain. Archs int. Pharmacodyn. Thér., 141, 520524.
  • Bóse, B.C., Saifi, A.Q. & Bhagat, A.W. (1964). Observations on the pharmacological actions of cannabis indica. Part II. Archs int. Pharmacodyn. Thér., 147, 285290.
  • Carlsson, A., Fuxe, K., Hamberger, B.Z. & Lindquist, M. (1966). Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurones. Acta physiol. scand., 67, 481497.
  • Christensen, H.D., Freudenthal, R.I., Gidley, J.T., Rosenfeld, R., Boegli, G., Testino, L., Brine, D.R., Pitt, C.G. & Wall, M.E. (1971). Activity of Δ8 and Δ9-tetrahydrocannabinol and related compounds in the mouse. Science, 172, 165167.
  • Colombine, C.E., Westfall, T.C. & McCoy, E.E. (1970). The changes in vitamin B6 and brain amine metabolism in mice chronically treated with Δ9-tetrahydrocannabinol. Proc. 7th Congress of the C.I.N.P., Prague, Czechoslovakia.
  • Corrodi, H. & Hanson, L.C.F. (1966). Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berl.), 10, 116125.
  • Garriott, J.C., Forney, R.B., Hughes, F.W. & Richards, A.B. (1968). Pharmacologic properties of some cannabis related compounds. Archs int. Pharmacodyn. Thér., 171, 425434.
  • Garriott, J.C., King, L.J., Forney, R.B. & Hughes, F.W. (1967). Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice. Life Sciences, 6, 21192128.
  • Gill, E.W., Paton, W.D.M. & Pertwee, R.G. (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature, Lond., 228, 134136.
  • Herrington, L.P. (1940). The heat regulation of small laboratory animals at various environmental temperatures. Am. J. Physiol., 129, 123139.
  • Holtzman, D., Lovell, R.A., Jaffe, J.H. & Freedman, D.X. (1969). (1)-Δ9-tetrahydrocannabinol neurochemical and behavioural effects in the mouse. Science, 163, 14641467.
  • Koe, B.K. & Weissman, A. (1966). p-Chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmac. exp. Ther., 154, 499516.
  • Krantz, J.C., Berger, H.J. & Welch, B.L. (1971). Blockade of (–)-trans-Δ9-tetrahydrocannabinol depressant effect by cannabinol in mice. Amer. J. Pharmacy, 143, 149152.
  • Kubena, R.K. & Barry, H. (1970). Interactions of Δ1-tetrahydrocannabinol with barbiturates and methamphetamine. J. Pharmac. exp. Ther., 173, 94100.
  • Loewe, S. (1944). Studies on the pharmacology of marihuana. In: The marihuana problems in the City of New York, by the Mayors Committee on Marihuana, pp. 149212. Lancaster, Pa: The Jaques Cattell Press.
  • Maître, L. (1971). Effects of some cannabinols on biosynthesis of brain amines and on pituitary response in the rat. In: Symposium on the chemistry and biological activity of cannabis Acta Pharmac. Suecica p. 693.
  • Paton, W.D.M. (1968). Drug dependence—a socio-pharmacological assessment. Advancement of Science, December, 1968. pp. 200212.
  • Paton, W.D.M. & Pertwee, R.G. (1972). Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Br. J. Pharmac., 44, 250261.
  • Phillips, R.N., Brown, D.J. & Forney, R.B. (1971). Enhancement of depressant properties of alcohol or barbiturates in combination with aqueous suspended Δ9-tetrahydrocannabinol in rats. J. Forensic Sciences, 16, 152161.
  • Ross, S.B. & Renyi, A.L. (1967). Inhibition of the uptake of tritiated catecholamines by anti-depressant and related agents. Europ. J. Pharmac., 2, 181186.
  • Shafer, R.P. (1972). National Commission on Marihuana and Drug abuse. Appendix Vol. 1. U.S. Government Printing Office, Washington, D.C..
  • Spector, S., Sjoerdsma, A. & Udenfriend, S. (1965). Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmac. exp. Ther., 147, 8695.
  • Whittle, B.A. (1964). The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics. Br. J. Pharmac., 22, 246253.